REFERENCES
1. Singh G, Daus G, Allender M, et al. Social Determinants of Health in the United States: Addressing Major Health Inequality Trends for the Nation, 1935-2016. Int J MCH AIDS . 2017;6(2):139-164. doi:10.21106/ijma.236
2. Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (with CD) .; 2003. doi:10.17226/12875
3. Marmot M, Friel S, Bell R, Houweling TA, Taylor S. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet . 2008;372(9650):1661-1669. doi:10.1016/S0140-6736(08)61690-6
4. Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy. CA Cancer J Clin . 2020;70(1):31-46. doi:10.3322/caac.21586
5. Sayani A. Health equity in national cancer control plans: An analysis of the ontario cancer plan. Int J Heal Policy Manag . 2019;8(9):550-556. doi:10.15171/ijhpm.2019.40
6. Temkin SM, Rimel BJ, Bruegl AS, Gunderson CC, Beavis AL, Doll KM. A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review.Gynecol Oncol . 2018;149(1):70-77. doi:10.1016/j.ygyno.2017.11.013
7. Ward E, Jemal A, Cokkinides V, et al. Cancer Disparities by Race/Ethnicity and Socioeconomic Status. CA Cancer J Clin . 2004;54(2):78-93. doi:10.3322/canjclin.54.2.78
8. Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: A population-based study in Ontario, Canada. Cancer . 2010;116(17):4160-4167. doi:10.1002/cncr.25427
9. WHO. WHO Report on Cancer: Setting Priorities Investing Wisely and Providing Care for All. ; 2020.
10. McDaniel JT, Nuhu K, Ruiz J, Alorbi G. Social determinants of cancer incidence and mortality around the world: an ecological study.Glob Health Promot . 2019;26(1):41-49. doi:10.1177/1757975916686913
11. Yap ML, Oar A, Moraes FY, Ilbawi A. An Evidence-Based National Cancer Control Program (NCCP) Quality Assessment Checklist. J Glob Oncol . 2018. doi:10.1200/jgo.18.66800
12. Felix AS, Brinton LA. Cancer progress and priorities: Uterine cancer. Cancer Epidemiol Biomarkers Prev . 2018;27(9):985-994. doi:10.1158/1055-9965.EPI-18-0264
13. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: Socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health . 2004;94(12):2104-2111. doi:10.2105/AJPH.94.12.2104
14. Robinson KM, Christensen KB, Ottesen B, Krasnik A. Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer. Eur J Cancer Care (Engl) . 2011;20(5):653-661. doi:10.1111/j.1365-2354.2011.01259.x
15. Doll KM, Winn AN, Goff BA. Untangling the Black-White mortality gap in endometrial cancer: a cohort simulation. Am J Obstet Gynecol . 2017;216(3):324-325. doi:10.1016/j.ajog.2016.12.023
16. Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: Evidence from patients with female breast,lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol . 2013;24(3):843-850. doi:10.1093/annonc/mds526
17. Svanvik T, Marcickiewicz J, Sundfeldt K, Holmberg E, Strömberg U. Sociodemographic disparities in stage-specific incidences of endometrial cancer: a registry-based study in West Sweden, 1995–2016. Acta Oncol (Madr) . 2019;58(6):845-851. doi:10.1080/0284186X.2019.1581947
18. Strohl AE, Feinglass JM, Shahabi S, Simon MA. Surgical wait time: A new health indicator in women with endometrial cancer. Gynecol Oncol . 2016;141(3):511-515. doi:10.1016/j.ygyno.2016.04.014
19. Fader AN, Matsuno Weise R, Sinno AK, et al. Utilization of minimally invasive surgery in endometrial cancer care: A Quality and cost disparity. In: Obstetrics and Gynecology . Vol 127. ; 2016:91-100. doi:10.1097/AOG.0000000000001180
20. Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC. Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis. Gynecol Oncol . 2016;143(1):98-104. doi:10.1016/j.ygyno.2016.07.107
21. Bregar AJ, Alejandro Rauh-Hain J, Spencer R, et al. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis. Gynecol Oncol . 2017;145(1):114-121. doi:10.1016/j.ygyno.2017.01.024
22. Foote JR, Gaillard S, Broadwater G, et al. Disparities in the surgical staging of high-grade endometrial cancer in the United States.Gynecol Oncol Res Pract . 2017;4(1):1-8. doi:10.1186/s40661-016-0036-3
23. Osborn V, Schwartz D, Lee YC, et al. Patterns of care of IMRT usage in postoperative management of uterine cancer. Gynecol Oncol . 2017;144(1):130-135. doi:10.1016/j.ygyno.2016.11.017
24. Yap OWS, Matthews RP. Racial and ethnic disparities in cancers of the uterine corpus. J Natl Med Assoc . 2006;98(12):1930-1933.
25. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endometrial cancer.J Clin Oncol . 2003;21(22):4200-4206. doi:10.1200/JCO.2003.01.218
26. Sud S, Holmes J, Eblan M, Chen R, Jones E. Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis. Gynecol Oncol . 2018;148(2):349-356. doi:10.1016/j.ygyno.2017.12.021
27. Dolly D, Mihai A, Rimel BJ, et al. A delay from diagnosis to treatment is associated with a decreased overall survival for patients with endometrial cancer. Front Oncol . 2016;6(FEB):1-5. doi:10.3389/fonc.2016.00031
28. OECD Interactive Tool: International Comparisons — Peer Countries, Ontario .; 2019. https://www.cihi.ca/en/oecd-interactive-tool-peer-countries-on.
29. Kumachev A, Trudeau ME, Chan KKW. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario’s experience. Cancer . 2016;122(6):893-898. doi:10.1002/cncr.29838
30. Kagedan DJ, Abraham L, Goyert N, et al. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer. Cancer . 2016;122(20):3175-3182. doi:10.1002/cncr.30148
31. Anderson LN, Cotterchio M, Boucher BA, Kreiger N. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Int J Cancer . 2013;132(7):1683-1692. doi:10.1002/ijc.27788
32. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet . 2015;385(9972):977-1010. doi:10.1016/S0140-6736(14)62038-9
33. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol . 1992;45(6):613-619. doi:10.1016/0895-4356(92)90133-8
34. Soobader MJ, LeClere FB, Hadden W, Maury B. Using aggregate geographic data to proxy individual socioeconomic status: Does size matter? Am J Public Health . 2001;91(4):632-636. doi:10.2105/AJPH.91.4.632
35. Matheson FI, Dunn JR, Smith KLW, Moineddin R, Glazier RH. Development of the Canadian Marginalization index: A new tool for the study of inequality. Can J Public Heal . 2012;103(SUPPL.2):3-5. doi:10.17269/cjph.103.3096
36. McDonald JT, Farnworth M, Liu Z. Cancer and the healthy immigrant effect: a statistical analysis of cancer diagnosis using a linked Census-cancer registry administrative database. BMC Public Health . 2017;17(1):1-14. doi:10.1186/s12889-017-4190-2
37. Cooper N, Quinn MJ, Rachet B, Mitry E, Coleman MP. Survival from cancer of the uterus in england and wales up to 2001. Br J Cancer . 2008;99:S65-S67. doi:10.1038/sj.bjc.6604591
38. Stanbury JF, Baade PD, Yu Y, Yu XQ. Cancer survival in New South Wales, Australia: Socioeconomic disparities remain despite overall improvements. BMC Cancer . 2016;16(1):48. doi:10.1186/s12885-016-2065-z
39. Hughes MC, Baker TA, Kim H, Valdes EG. Health behaviors and related disparities of insured adults with a health care provider in the United States, 2015–2016. Prev Med (Baltim) . 2019;120(December 2018):42-49. doi:10.1016/j.ypmed.2019.01.004
40. Danos D, Leonardi C, Gilliland A, et al. Increased risk of hepatocellular carcinoma associated with neighborhood concentrated disadvantage. Front Oncol . 2018;8(SEP):1-9. doi:10.3389/fonc.2018.00375
41. Jensen KE, Hannibal CG, Nielsen A, et al. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer . 2008;44(14):2003-2017. doi:10.1016/j.ejca.2008.06.014
42. Wen X, Wen D, Yang Y, Chen Y, Wang G, Shan B. Urban-Rural Disparity in Helicobacter Pylori Infection–Related Upper Gastrointestinal Cancer in China and the Decreasing Trend in Parallel with Socioeconomic Development and Urbanization in an Endemic Area. Ann Glob Heal . 2017;83(3-4):444-462. doi:10.1016/j.aogh.2017.09.004
43. Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer . 2019;145(7):1719-1730. doi:10.1002/ijc.31961
44. Allen NE, Key TJ, Dossus L, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer . 2008;15(2):485-497. doi:10.1677/ERC-07-0064
45. Feinberg J, Albright B, Black J, et al. Ten-year comparison study of type 1 and 2 endometrial cancers: Risk factors and outcomes.Gynecol Obstet Invest . 2019;84(3):290-297. doi:10.1159/000493132
46. Busch EL, Crous-Bou M, Prescott J, et al. Endometrial cancer risk factors, hormone receptors, and mortality prediction. Cancer Epidemiol Biomarkers Prev . 2017;26(5):727-735. doi:10.1158/1055-9965.EPI-16-0821
47. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over the life course and obesity: Systematic review and meta-analysis. Xiao G, ed. PLoS One . 2017;12(5):e0177151. doi:10.1371/journal.pone.0177151
48. Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol . 2012;126(2):176-179. doi:10.1016/j.ygyno.2012.04.013
49. Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK. Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol . 2014;37(2):131-134. doi:10.1097/COC.0b013e318277d5f4